Oxygenation and lung morphology in a rabbit pediatric ARDS- model under high peak pressure ventilation plus nitric oxide and surfactant compared with veno-venous ECMO

International Journal of Artificial Organs

Volumn 22, Issue 11, 1999, Pages 747-753

  Möller, Jens Christian ^a   Reiss, I ^a   Schaible, T F ^a   Kohl, M ^a   Gopel W ^a   Fischer, T ^a   Nitsche, E M ^a   Kruger S ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ARDS; Baro ergotrauma; Nitric oxide; Permissive hypercapnia; Surfactant

Indexed keywords

NITRIC OXIDE; OXYGENATION; RESPIRATORY THERAPY;

ARDS; BARO/ERGOTRAUMA; BAROTRAUMA; EXPANSION INDEX; HYPERCAPNIA; INHALED NITRIC OXIDE; LUNG MORPHOLOGY; PEAK PRESSURE; PERMISSIVE HYPERCAPNIUM; THERAPEUTIC STRATEGY;

SURFACE ACTIVE AGENTS;

IONIC SURFACTANT; NITRIC OXIDE;

AERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAROTRAUMA; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; HYPERCAPNIA; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG LAVAGE; LUNG VENTILATION; NONHUMAN; RABBIT; RESPIRATORY DISTRESS SYNDROME; TIDAL VOLUME;

EID: 0343920842     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902201108     Document Type: Article

References (31)

1. Möller JC, Raszynski A, Richter A, Tegtmeyer FK. The prognostic value of initial respiratory parameters in pediatric ARDS. Anaesthesist 1992; 41: 399-402.
2. Amato MBP, Barbas CS, Medeiros DM et al. Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-54.
3. Möller JC, Schaibel TF, Reiss I, Artlich A, Gortner L. Treatment of severe non-neonatal ARDS in children with surfactant and nitric oxide in a "pre ECMO" - situation. Int J Artif Organs 1995; 18: 598-602.
4. Keszler M, Klappenbach S, Reardon E. Lung pathology after high frequency jet ventilation combined with low rate intermittent mandatory ventilation in a canine model of meconium aspiration. Pediatr Pulmonol 1988; 4: 144-9.
5. Keszler M, Ryckman FC, Mc Donald JV et al. A prospective, multicenter, randomized study of high versus low positive end-expiratory pressure during ECMO. J Pediatr 1992; 120: 107-13.
6. Gattinoni L, Pelosi P, Crotti S, Valenza F. Effects of positive pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1807-14.
7. Tsumo K, Prato P, Kolobow T. Acute lung injury from mechanical ventilation at moderately high airway pressures. J Appl Physiol 1990; 69: 956-61.
8. Tsuno K, Miura K, Takeya M, Kolobow T, Morioka T. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 1991; 143: 1115-20.
9. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 1985; 30: 321-8.
10. Lachmann B, Grossmann G, Nilsson R, Robertson B. Effect of supplementary surfactant on in vivo lung mechanics in the premature neonate. Eur J Pediatr 1981; 136: 173-9.
11. Möller JC. Surfactant therapy for acute respiratory distress syndrome (infantile ARDS). In: Wauer RR ed. Surfactant therapy. Stuttgard: Thieme 1998; 133-45.
12. Robertson B. Surfactant inactivation and surfactant replacement in experimental models of ARDS. Acta Anaesthesiol Scand 1991; (suppl. 95): S22-8.
13. Seeger W, Günther A, Walmrath HD, Grimminger F, Lasch HG. Alveolar surfactant and ARDS. Clin Investig 1993; 71: 177-90.
14. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-33.
15. John J, Taskar V, Evander E, Wollmer P, Jonson B. Additive nature of distension and surfactant pertubation on alveolocapillary permeability. Eur Respir J 1997; 10: 192-9.
16. Möller JC, Reiss I, Schaible TF, Tegtmeyer FK, Gortner L. Surfactant treatment in children with acquired respiratory distress syndrome. Mschr Kinderheilkd 1995; 143: 685-90.
17. Verbrugge SJ, de Anda V, Gommers D, Neggers SJ, Sorm V, Bohm SH, Lachmann B. Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation induced lung injury. Anaesthesiology 1998; 89: 467-74.
18. Verbrugge SJ, Bohm SH, Gommers D, Zimmerman LJ, Lachmann B. Surfactant impairment after mechanical ventilation with large alveolar surface area changes and effects of positive end-expiratory pressure. Br J Anaesth 1998; 80: 360-4.
19. Plötz FB. Surfactant and extracorporeal life support by Universiteitsdukkerij Groningen, Groningen (Proefschrift) 1992.
20. Shah NS, Nakayama DK, Jacob TD, et al. Efficacy of inhaled nitric oxide in oleic acid induced acute lung injury. Crit Care Med 1997; 25: 153-8.
21. Abman SH, Griebel JL, Parker DK. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994; 124: 881-8.
22. Kühl PG, Appel R, Lasch P, Möller J, Bindl L. ARDS in pediatrics, results of a survey in German children's hospitals and recommendation of the "working group pediatric ARDS" on respiratory management. Mschr Kinderheilkd 1996; 114: 1110-16.
23. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension: a prospective randomized study. Pediatrics 1989; 89: 957-63.
24. UK Collaborative ECMO Trial Group. UK Collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-82.
25. Otsu T, Merz SI, Hultquist KA, et al. Laboratory evaluation of a double lumen catheter for venovenous neonatal ECMO. ASAIO Trans 1989; 35: 647-50.
26. Moler FW, Palmisano JM, Custer JR, Meliones JN, Bartlett RH. Alveolar-arterial oxygen gradients before ECLS for severe pediatric respiratory failure: improved outcome for ECLS managed patients. Crit Care Med 1994; 22: 620-5.
27. Verbrugge SJC, Gommers D, Bos JAH. Pulmonary 99m-Tc serum albumin clearance and effects of surfactant replacement after lung lavage in rabbits. Crit Care Med 1996; 24: 1518-23.
28. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality in ARDS using low volume, pressure limited ventilation with permissive hypercapnia, a prospective study. Crit Care Med 1994; 22: 1568-78.
29. Kolobow T, Moretti MP, Fumagalli R, et al.Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 1987; 135: 312-5.
30. Hartog A, Gommers D, van't Veen A, Erdmann W, Lachmann B. Exogenous surfactant and nitric oxide have a synergistic effect in improving gas exchange in experimental ARDS. Adv Exp Med Biol 1997; 428: 277-9.
31. Gommers D, Hartog A, van't Veen A, Lackmann B. Improved oxygenation by nitric oxide is enhanced by prior lung reaeration with surfactant, rather than positive end-expiratory pressure, in lung lavaged rabbits. Crit Care Med 1997; 25: 1868-73.